Dystonia



Dystonia


Stanley Fahn



INTRODUCTION

After parkinsonism, dystonia is the most common movement disorder encountered in movement disorder clinics. The term dystonia was coined by Oppenheim in 1911 to indicate that the disorder he was describing manifested hypotonia at one occasion and tonic muscle spasms at another, usually but not exclusively elicited on volitional movements. Although the term dystonia has undergone various definitions since 1911, the most recent definition is: “Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive, movements, postures, or both. Dystonic movements are typically patterned, twisting, and may be tremulous. Dystonia is often initiated or worsened by voluntary action and associated with overflow muscle activation.”

Limb, axial, and cranial voluntary muscles can all be affected by dystonia. The abnormal movements are often exacerbated during voluntary movements, so-called action dystonia.

If the dystonic contractions appear only with a specific action, it is referred to as task-specific dystonia (e.g., writer’s cramp and musician’s cramp). As the dystonic condition progresses, voluntary movements in parts of the body not affected with dystonia can induce dystonic movements of the involved body part, so-called overflow. Talking is a common activity that causes overflow dystonia in other body parts. With further progression, the affected part can develop dystonic movements while at rest, and sustained abnormal postures may be the eventual outcome.

Dystonic movements tend to increase with fatigue, stress, and emotional states; they tend to be suppressed with relaxation, hypnosis, and sleep. Dystonia often disappears during deep sleep, unless the movements are extremely severe. A characteristic and almost unique feature of dystonic movements is that they can be diminished by tactile or proprioceptive “sensory tricks” (gestes antagoniste). For example, patients with cervical dystonia (torticollis) often place a hand on the chin or side of the face to reduce nuchal contractions, and orolingual dystonia is often helped by touching the lips or placing an object in the mouth. Lying down may reduce truncal dystonia; walking backward or running may reduce leg dystonia.

Rapid muscle spasms that occur in a repetitive pattern may be present in torsion dystonia; when rhythmic, the term dystonic tremor is applied. Rarely, some children and adolescents with primary or secondary dystonia may experience a crisis, a sudden increase in the severity of dystonia, which has been called dystonic storm or status dystonicus. This can cause myoglobinuria with a threat of death by renal failure. These patients require treatment in an intensive care unit (ICU) using sedating agents such as propofol and midazolam, intrathecal baclofen, and in some cases, emergency deep brain stimulation of the internal globus pallidus.


EPIDEMIOLOGY

Epidemiologic studies in dystonia typically segregate patients with dystonia into primary (no known cause or no known lesion) and secondary (an environmental or hereditary lesion in the brain) and into focal, segmental, and generalized forms of dystonia. An epidemiologic study of primary dystonia in the population living in Rochester, Minnesota, found the prevalence of generalized dystonia to be 3.4 per 100,000 population and the prevalence of focal dystonia to be 30 per 100,000. The frequency of primary dystonia in the Ashkenazi Jewish population is much higher (between 1/6,000 and 1/2,000) because this population descends from a limited group of founders of the DYT1 mutation. The origin of the mutation was traced to the northern part of the historic Jewish Pale of settlement (Lithuania and Byelorussia) approximately 400 years ago. Focal dystonia is more common than segmental dystonia, and generalized dystonia is very infrequent, about one-tenth as common as focal dystonia. The prevalence rate of focal dystonias varies in different countries, being slightly lower in Japan (between 6 and 14 per 100,000) than in Western Europe (between 11 and 14 per 100,000).


PATHOBIOLOGY


PATHOLOGY

Dystonia is considered a disorder of the central nervous system, with neuropathology showing structural lesions in degenerative forms of dystonia (e.g., Wilson disease and neurodegenerations with brain iron accumulation) and static lesions (e.g., post stroke, post trauma) and those with no structural lesion in the primary dystonias, some metabolic disorders (e.g., dopa-responsive disorder due to genetic mutations causing reduced synthesis of dopamine), and tardive dystonia (due to a persistent complication of dopamine receptor-blocking agents; see Chapter 80). When structural lesions are found in the brain associated with degenerative diseases and environmental insults, the putamen or its connections (including thalamus and cerebral cortex) are the regions affected.


ETIOLOGY

Dystonia can be caused by genetic mutations (inherited dystonia, discussed in the following section) and environmental insults

(acquired dystonia), but by far, the most common are dystonias without a known cause (idiopathic dystonia). The last group makes up the majority of focal dystonias. The acquired dystonias are listed in Table 76.1. Most of the causes in this table result in structural lesions, but two do not—drug-induced and psychogenic dystonia.


GENETICS

A large number of gene mutations have been discovered to cause both primary (nonstructural) dystonia and degenerative dystonia.

Table 76.2 lists the heredodegenerative dystonias. These are divided into autosomal dominant, autosomal recessive, X-linked, and mitochondrial disorders. Typically, these diseases result in progressive degenerative changes in the basal ganglia and their connections. These can usually be detected by magnetic resonance
imaging (MRI) and a metabolic workup. Neurodegenerations with brain iron accumulations (NBIAs) are clinically detected by the presence of high iron content in the globus pallidus and other brain regions where there is decreased signal intensity T2-weighted images. Table 76.3 lists the gene mutations in the NBIAs.








TABLE 76.1 Causes off Acquiirred Dysttoniia



















































































































1.


Perinatal cerebral injury



a.


Athetoid cerebral palsy



b.


Delayed-onset dystonia


2.


Encephalitis, infections, and post infections



a.


Poststreptococcal



b.


Subacute sclerosing leukoencephalopathy



c.


Progressive multifocal leukoencephalopathy



d.


Creutzfeldt-Jakob disease



e.


HIV/AIDS



f.


Abscess


3.


Head trauma


4.


Paraneoplastic syndromes


5.


Primary antiphospholipid syndrome


6.


Focal cerebral vascular injury


7.


Arteriovenous malformation


8.


Hypoxia


9.


Brain tumor


10.


Multiple sclerosis


11.


Cervical cord injury or lesion


12.


Lumbar canal stenosis


13.


Peripheral injury


14.


Electrical injury


15.


Drug-induced



a.


Levodopa



b.


Dopamine D2 receptor-blocking agents




i. Acute dystonic reaction




ii. Tardive dystonia



c.


Ergotism



d.


Anticonvulsants


16.


Toxins—Mn, CO, carbon disulfide, cyanide, methanol, disulfiram, 3-nitroproprionic acid


17.


Metabolic—hypoparathyroidism


18.


Psychogenic


Mn, manganese; CO, carbon monoxide.


The majority of patients with dystonia are without structural lesions in the brain. These so-called primary dystonias can be genetic or idiopathic. The genetic forms began to be classified by geneticists with a DYT1 label. But the labeling has become a mixed bag with both primary dystonias and one heredodegenerative dystonia being in this list. Unfortunately, the paroxysmal dyskinesias were also classified with a DYT label, when in fact these disorders should have been labeled as a separate entity. Table 76.4 provides the DYT classification.








TABLE 76.2 Heredodegenerative Diseases (Typically Not Pure Dystonia)
















































































































































Autosomal dominant



a. Huntington disease



b. Machado-Joseph disease (SCA3)



c. Other SCA subtypes (e.g., SCA2, 6, 17)



d. Familial basal ganglia calcification (Fahr disease)



e. Frontotemporal dementia (FTD)



f. Dentatorubropallidoluysian atrophy (DRPLA)



g. NBIA3/neuroferritinopathy


Autosomal recessive



a. Juvenile parkinsonism (parkin)



b. Wilson disease



c. Glutaric acidemia



d. NBIA1/pantothenic kinase associated neurodegeneration (PKAN)



e. NBIA2/infantile neuroaxonal dystrophy (INAD)/PLAN for phospholipase A2 deficiency



f. NBIA4/mitochondrial membrane protein-associated neurodegeneration (MPAN)



g. NBIA6/coenzyme A synthase protein-associated neurodegeneration (CoPAN)



h. Aceruloplasminemia (one of the NBIAs)



i. Fatty acid hydroxylase neurodegeneration (FAHN) (one of the NBIAs)



j. Gangliosidoses (GM1, GM2)



k. Dystonic lipidosis/Niemann-Pick, type C (NPC1)



l. Juvenile neuronal ceroid-lipofuscinosis



m. Metachromatic leukodystrophy



n. Homocystinuria



o. Propionic acidemia



p. Methylmalonic aciduria



q. Hartnup disease



r. Ataxia telangiectasia



s. Ataxia with vitamin E deficiency



t. Ataxia with ocular apraxia type 2



u. Neuroacanthocytosis



v. Neuronal intranuclear inclusion disease



w. Friedreich ataxia


X-linked recessive and dominant



a. Lubag (X-linked dystonia-parkinsonism; DYT3)



b. Pelizaeus-Merzbacher disease



c. Deafness/dystonia syndrome



d. Lesch-Nyhan syndrome



e. Rett syndrome



f. NBIA5/beta-propeller protein-associated neurodegeneration (BPAN)


Mitochondrial



a. Leigh disease



b. Leber disease



c. MERRF/MELAS


Complex etiology (multifactorial)



a. Parkinson disease



b. Progressive supranuclear palsy



c. Multiple system atrophy



d. Cortical-basal degeneration


SCA, spinocerebellar ataxia; NBIA, neurodegeneration with brain iron accumulation; PLAN, PLA2G6-associated neurodegeneration; MERRF, myoclonic epilepsy with ragged red fibers; MELAS, myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.


Adapted and updated from Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol. 1998;78:1-10.



Jul 27, 2016 | Posted by in NEUROLOGY | Comments Off on Dystonia

Full access? Get Clinical Tree

Get Clinical Tree app for offline access